Cathie Wood Likes That: 3 IPO Plays She Bought on Monday
Cathie Wood is back in the IPO spotlight. This piece breaks down the three newly public names Ark Invest reportedly a...
Using Index Level to adjust risk lets you scale exposure in line with market momentum, maintaining a balanced, rules-based approach.
27,393 articlesCathie Wood is back in the IPO spotlight. This piece breaks down the three newly public names Ark Invest reportedly a...
May brings renewed focus on national security and market resilience. This guide identifies a top defense stock and sh...
AI demand is reshaping semiconductors, putting Micron and Intel in the spotlight. This guide breaks down which could ...
NuScale Power stock has been under pressure as investors digest macro concerns and regulatory headwinds. This guide b...
SpaceX stock has swung wildly since its debut, raising a simple question for every investor: is spacex stock: $150? a...
New data show the Austin metro added about 357,000 households from 2014 to 2024, a 51% rise that dwarfs the national ...
New data highlights a tougher entry to the workforce for Gen Z graduates compared with Millennials, with a large shar...
ASML’s price sits near the $1,800 mark, sparking questions about a possible stock split. This guide explains what a s...
A controversial post and a geopolitical rumor collide with everyday money concerns. This article shows how to transla...
What could Alphabet stock be worth half a decade from now? This article builds scenarios around AI capital spending, ...
Open Lending is shaping fintech funding with open partnerships and data-driven risk management. This deep dive untang...
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...